Oragenics

+$0.009 (+1.51%) Today
+$0.001 (+0.17%) As of 11:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Oragenics and other ETFs, options, and stocks.

About OGEN

Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of antibiotics and genetically engineered bacterial strains.

CEO
Michael O'Keefe Sullivan
Employees
7
Headquarters
Tampa, Florida
Founded
1996

OGEN Key Statistics

Market Cap
70.30M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.45M
High Today
$0.6249
Low Today
$0.5975
Open Price
$0.5975
Volume
2.94M
52 Week High
$1.80
52 Week Low
$0.377

OGEN Earnings

-$0.24
-$0.16
-$0.08
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure